Transaction Details

Footnotes

The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on November 4, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2016 and are scheduled to expire on March 1, 2026. | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $125.00 - $125.94 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. | The options became fully exercisable on March 1, 2019, the third anniversary of the grant date. | The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. | The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. | The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. | The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. | The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. | The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. | One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. | One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. | One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.